Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

103 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Transarterial embolization (TAE) as add-on to percutaneous radiofrequency ablation (RFA) for the treatment of renal tumors: Review of the literature, overview of state-of-the-art embolization materials and further perspective of advanced image-guided tumor ablation.
Sommer CM, Pallwein-Prettner L, Vollherbst DF, Seidel R, Rieder C, Radeleff BA, Kauczor HU, Wacker F, Richter GM, Bücker A, Rodt T, Massmann A, Pereira PL. Sommer CM, et al. Among authors: massmann a. Eur J Radiol. 2017 Jan;86:143-162. doi: 10.1016/j.ejrad.2016.10.024. Epub 2016 Nov 2. Eur J Radiol. 2017. PMID: 28027741 Review.
Comparison of self-gated and prospectively triggered fast low angle shot (FLASH) sequences for contrast-enhanced magnetic resonance imaging of the liver at 9.4 T in a rat model of colorectal cancer metastases.
Fries P, Seidel R, Müller A, Matthes K, Denda G, Massmann A, Menger MD, Sperling J, Morelli JN, Altmeyer K, Schneider G, Buecker A. Fries P, et al. Among authors: massmann a. Invest Radiol. 2013 Oct;48(10):738-44. doi: 10.1097/RLI.0b013e318294dd0e. Invest Radiol. 2013. PMID: 23695083
Evaluation of Gadopiclenol and P846, 2 High-Relaxivity Macrocyclic Magnetic Resonance Contrast Agents Without Protein Binding, in a Rodent Model of Hepatic Metastases: Potential Solutions for Improved Enhancement at Ultrahigh Field Strength.
Fries P, Massmann A, Robert P, Corot C, Laschke MW, Schneider G, Buecker A, Müller A. Fries P, et al. Among authors: massmann a. Invest Radiol. 2019 Sep;54(9):549-558. doi: 10.1097/RLI.0000000000000572. Invest Radiol. 2019. PMID: 31033675
103 results